Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
CERo Therapeutics Holdings, Inc. (CERO) had Return on Tangible Equity of 63.57% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.89M |
|
-- |
|
-- |
|
$4.85M |
|
$-4.85M |
|
$-1.04M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-4.85M |
|
$-4.43M |
|
28.76M |
|
28.76M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$1.57M |
|
$0.18M |
|
$0.63M |
|
$2.21M |
|
$11.33M |
|
$0.14M |
|
$0.14M |
|
$11.46M |
|
$-16.48M |
|
$-9.26M |
|
$-9.26M |
|
36.01M |
|
| Cash Flow Statement Financials | |
$-2.76M |
|
-- |
|
$1.96M |
|
$1.66M |
|
$0.86M |
|
$-0.80M |
|
$1.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-0.01 |
|
-0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.76M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.72% |
|
|
Return on Tangible Equity |
63.57% |
-266.92% |
|
64.52% |
|
$-0.26 |
|
$-0.10 |
|
$-0.10 |
|